Re-Engineering Clinical Trials: Best Practices for Streamlining the Development Process

0 avg rating
( 0 ratings by GoodReads )
 
9780124202467: Re-Engineering Clinical Trials: Best Practices for Streamlining the Development Process

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness. * Highlights the latest paradigm-shifts and innovation advances in clinical research * Offers easy-to-find best practice sections, lists of current literature and resources for further reading and useful solutions to day-to-day problems in current drug development * Discusses important topics such as safety profiling, data mining, site monitoring, change management, increasing development costs, key performance indicators and much more

"synopsis" may belong to another edition of this title.

About the Author:

Peter Sch ler is Senior Vice President, Global Medical & Safety Services, ICON Plc. Peter is board certified in neurology (1996; German Medical Board) and in Pharmaceutical Medicine (2001; Swiss Medical Association). In 1999 in obtained a Certificate in Business Administration by Henley Management College, UK. After his medical education he started is professional career in 1987 at the Medical Imaging Application Center of Siemens AG Medical Solutions. The same year he started at the Department of Experimental Neuropsychiatry of the Neurological University Hospital Erlangen, Germany. During the coming 8 years he was involved in basic and clinical CNS research. He held the position of Secretary General of the German section of the International League Against Epilepsy (ILAE; 1991-1995) and was awarded two scientific awards (Alfred-Hauptman epilepsy prize and ILAE Young Investigator Award). In 1995 he joined Pharmacia. During that period, he participated in the launch of two NCEs in the indications Parkinson's and major depression. In October 2000 he moved into the CRO business, building a department for Medical Affairs and also taking over responsibilities for clinical operations in Germany, Austria and Switzerland. In 2007, Peter joined ICON, now overseeing over 360 people located in 11 major offices in Argentina, Brazil, Germany, India, Japan, Latvia, Mexico, Poland, Singapore, UK and US. He issued several publications on drug safety and authored an eBook about clinical trial design and conduct (Zenosis Ltd publisher) and continues to lecture Pharmaceutical Medicine at the Universities of Duisburg-Essen, Germany and Aveiro, Portugal. Brendan Buckley is Chief Medical Officer of ICON Plc. He was previously a co-founder of Firecrest Clinical. He is a Honorary Clinical Professor in the School of Medicine at University College Cork Ireland. A medical graduate of the National University of Ireland and a doctoral graduate in Biochemistry of Oxford University, he has over 30 years' experience in clinical pharmacology research. Prior to joining ICON, he was Director of the European collaborative Centre for Clinical Trials in Rare Diseases at Cork. He was a member of the EMA Committee for Orphan Medicinal Products (COMP) from 2000-2003 and a member of the EMA Scientific Advisory Committee on Diabetes and Metabolism until 2011. He was a member of the Board of Directors of the Irish Medicines Board, the national competent authority for Ireland, 2004-2011 and chaired its statutory Advisory Committee for Human Medicines. He is chairman of the independent data and safety monitoring boards for a number of large clinical trials programmes with several sponsors. He is a member of the scientific advisory boards of a number of research charities and honorary Director of the Cork Cancer Research Centre. Professor Buckley is a Fellow of the Royal College of Physicians of Ireland, of the College's Faculty of Pathology and a Fellow of the Faculty of Sports and Exercise Medicine.

About the Author:

Brendan Buckley is Chief Medical Officer of ICON Plc. He was previously a co-founder of Firecrest Clinical. He is a Honorary Clinical Professor in the School of Medicine at University College Cork Ireland. A medical graduate of the National University of Ireland and a doctoral graduate in Biochemistry of Oxford University, he has over 30 years' experience in clinical pharmacology research. Prior to joining ICON, he was Director of the European collaborative Centre for Clinical Trials in Rare Diseases at Cork. He was a member of the EMA Committee for Orphan Medicinal Products (COMP) from 2000-2003 and a member of the EMA Scientific Advisory Committee on Diabetes and Metabolism until 2011. He was a member of the Board of Directors of the Irish Medicines Board, the national competent authority for Ireland, 2004-2011 and chaired its statutory Advisory Committee for Human Medicines. He is chairman of the independent data and safety monitoring boards for a number of large clinical trials programmes with several sponsors. He is a member of the scientific advisory boards of a number of research charities and honorary Director of the Cork Cancer Research Centre. Professor Buckley is a Fellow of the Royal College of Physicians of Ireland, of the College's Faculty of Pathology and a Fellow of the Faculty of Sports and Exercise Medicine. Peter Sch ler is Senior Vice President, Global Medical & Safety Services, ICON Plc. Peter is board certified in neurology (1996; German Medical Board) and in Pharmaceutical Medicine (2001; Swiss Medical Association). In 1999 in obtained a Certificate in Business Administration by Henley Management College, UK. After his medical education he started is professional career in 1987 at the Medical Imaging Application Center of Siemens AG Medical Solutions. The same year he started at the Department of Experimental Neuropsychiatry of the Neurological University Hospital Erlangen, Germany. During the coming 8 years he was involved in basic and clinical CNS research. He held the position of Secretary General of the German section of the International League Against Epilepsy (ILAE; 1991-1995) and was awarded two scientific awards (Alfred-Hauptman epilepsy prize and ILAE Young Investigator Award). In 1995 he joined Pharmacia. During that period, he participated in the launch of two NCEs in the indications Parkinson's and major depression. In October 2000 he moved into the CRO business, building a department for Medical Affairs and also taking over responsibilities for clinical operations in Germany, Austria and Switzerland. In 2007, Peter joined ICON, now overseeing over 360 people located in 11 major offices in Argentina, Brazil, Germany, India, Japan, Latvia, Mexico, Poland, Singapore, UK and US. He issued several publications on drug safety and authored an eBook about clinical trial design and conduct (Zenosis Ltd publisher) and continues to lecture Pharmaceutical Medicine at the Universities of Duisburg-Essen, Germany and Aveiro, Portugal.

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Brendan Buckley
Published by Elsevier Science Publishing Co Inc, United States (2015)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 10
Seller
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2015. Hardback. Book Condition: New. 230 x 154 mm. Language: English . Brand New Book. The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness. Bookseller Inventory # AA59780124202467

More Information About This Seller | Ask Bookseller a Question

Buy New
59.52
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Peter Schuler, Brendan Buckley
Published by Academic Press 2015-01-08 (2015)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Quantity Available: 3
Seller
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Academic Press 2015-01-08, 2015. Book Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bookseller Inventory # NU-LBR-01529365

More Information About This Seller | Ask Bookseller a Question

Buy New
57.04
Convert Currency

Add to Basket

Shipping: 2.99
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Brendan Buckley
Published by Elsevier Science Publishing Co Inc, United States (2015)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 10
Seller
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2015. Hardback. Book Condition: New. 230 x 154 mm. Language: English . Brand New Book. The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness. Bookseller Inventory # AA59780124202467

More Information About This Seller | Ask Bookseller a Question

Buy New
63.16
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Schüler, Peter (Editor)/ Buckley, Brendan (Editor)
Published by Academic Pr (2014)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 2
Seller
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Academic Pr, 2014. Hardcover. Book Condition: Brand New. 360 pages. 9.00x6.00x1.00 inches. In Stock. Bookseller Inventory # __0124202462

More Information About This Seller | Ask Bookseller a Question

Buy New
59.30
Convert Currency

Add to Basket

Shipping: 6
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Schueler, Peter (EDT)/ Buckley, Brendan (EDT)
Published by Elsevier Science Publishing Co Inc 2014-12-19, San Diego (2014)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 1
Seller
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc 2014-12-19, San Diego, 2014. hardback. Book Condition: New. Bookseller Inventory # 9780124202467

More Information About This Seller | Ask Bookseller a Question

Buy New
60.99
Convert Currency

Add to Basket

Shipping: 4.50
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

SCHUELER, PETER; BUCKLEY, BRENDAN
Published by Academic Press (2014)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 1
Seller
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Academic Press, 2014. Hardback. Book Condition: NEW. 9780124202467 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0894717

More Information About This Seller | Ask Bookseller a Question

Buy New
61
Convert Currency

Add to Basket

Shipping: 8
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

SCHUELER, PETER; BUCKLEY, BRENDAN
Published by Academic Press (2014)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 1
Seller
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Academic Press, 2014. Hardback. Book Condition: NEW. 9780124202467 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE01198659

More Information About This Seller | Ask Bookseller a Question

Buy New
61
Convert Currency

Add to Basket

Shipping: 8
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Brendan Buckley
Published by Academic Press (2015)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 1
Seller
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Academic Press, 2015. Hardcover. Book Condition: New. book. Bookseller Inventory # 0124202462

More Information About This Seller | Ask Bookseller a Question

Buy New
75.18
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

9.

Brendan Buckley
Published by Academic Press (2014)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Hardcover Quantity Available: 1
Seller
Rating
[?]

Book Description Academic Press, 2014. Book Condition: New. Bookseller Inventory # L9780124202467

More Information About This Seller | Ask Bookseller a Question

Buy New
70.42
Convert Currency

Add to Basket

Shipping: 5.19
From Germany to U.S.A.
Destination, Rates & Speeds

10.

Peter Schüler
Published by Oxford Elsevier LTD Jan 2015 (2015)
ISBN 10: 0124202462 ISBN 13: 9780124202467
New Quantity Available: 1
Rating
[?]

Book Description Oxford Elsevier LTD Jan 2015, 2015. Buch. Book Condition: Neu. 236x156x30 mm. Neuware - The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness. 360 pp. Englisch. Bookseller Inventory # 9780124202467

More Information About This Seller | Ask Bookseller a Question

Buy New
66.80
Convert Currency

Add to Basket

Shipping: 10.38
From Germany to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book